Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) FCF Margin: 2016-2018

Historic FCF Margin for ENDRA Life Sciences (NDRA) over the last 1 years, with Mar 2018 value amounting to -39,713.15%.

  • ENDRA Life Sciences' FCF Margin was N/A to -39,713.15% in Q1 2018 from the same period last year, while for Mar 2018 it was -1,541.81%, marking a year-over-year change of. This contributed to the annual value of -6,836.54% for FY2024, which is 475554.00% down from last year.
  • Latest data reveals that ENDRA Life Sciences reported FCF Margin of -39,713.15% as of Q1 2018, which was down 97.76% from -20,081.52% recorded in Q4 2017.
  • Over the past 5 years, ENDRA Life Sciences' FCF Margin peaked at 361,465.66% during Q2 2016, and registered a low of -39,713.15% during Q1 2018.
  • Its 3-year average for FCF Margin is 49,899.52%, with a median of -1,083.98% in 2017.
  • Data for ENDRA Life Sciences' FCF Margin shows a maximum YoY slumped of 36,344,316bps (in 2017) over the last 5 years.
  • ENDRA Life Sciences' FCF Margin (Quarterly) stood at -105.93% in 2016, then slumped by 1,997,559bps to -20,081.52% in 2017, then reached -39,713.15% in 2018.
  • Its last three reported values are -39,713.15% in Q1 2018, -20,081.52% for Q4 2017, and -190.46% during Q3 2017.